Victoria Gutgarts
Overview
Explore the profile of Victoria Gutgarts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rashidi A, Youssef N, Workeneh B, Carsel A, Gutgarts V, Latcha S
Am J Nephrol
. 2025 Feb;
:1-20.
PMID: 39999798
Background: Electrolyte disorders are common in cancer patients and have significant impacts on treatment outcomes and quality of life. The frequency, severity, complexity and etiology of fluid and electrolyte disorders...
2.
Boardman A, Gutgarts V, Flynn J, Devlin S, Goldman A, Tomas A, et al.
Haematologica
. 2024 Nov;
110(3):651-664.
PMID: 39568416
Chimeric antigen receptor (CAR) T cells targeting CD19 induce durable remissions in patients with relapsed or refractory non-Hodgkin lymphoma (NHL), but many patients experience treatment-related toxicity. Cytokine release syndrome and...
3.
Chen M, Wilhelm C, Drilon A, Gutgarts V
J Thorac Oncol
. 2024 Nov;
19(11):e62-e63.
PMID: 39510707
No abstract available.
4.
Pak W, Brumwell N, Kabel C, Gutgarts V, Sathick I, Mailankody S, et al.
Kidney Med
. 2024 Aug;
6(8):100856.
PMID: 39100867
Chimeric antigen receptor (CAR) T-cell therapy against B-cell maturation antigen is a new treatment modality for relapsed or refractory multiple myeloma (MM). Patients with kidney failure and MM were excluded...
5.
Gutgarts V, Gerardine S, Shingarev R, Knezevic A, Zabor E, Latcha S, et al.
Kidney360
. 2024 May;
5(8):1094-1100.
PMID: 38814726
No abstract available.
6.
Chen M, Harada G, Liu D, DeMatteo R, Falcon C, Wilhelm C, et al.
J Thorac Oncol
. 2023 Sep;
19(1):153-159.
PMID: 37748692
Introduction: Select tyrosine kinase inhibitors (TKIs) used to treat oncogene-driven lung cancers also inhibit MATE-1. When MATE-1 is blocked, creatinine is retained in the serum. Elevated creatinine levels raise the...
7.
Adegbite B, Abramson M, Gutgarts V, Musteata F, Chauhan K, Muwonge A, et al.
Clin J Am Soc Nephrol
. 2023 Jun;
18(9):1175-1185.
PMID: 37382967
Background: Dasatinib has been associated with nephrotoxicity. We sought to examine the incidence of proteinuria on dasatinib and determine potential risk factors that may increase dasatinib-associated glomerular injury. Methods: We...
8.
Adegbite B, Abramson M, Gutgarts V, Musteata M, Chauhan K, Muwonge A, et al.
medRxiv
. 2023 May;
PMID: 37131844
Introduction: Dasatinib has been associated with nephrotoxicity. We sought to examine the incidence of proteinuria on dasatinib and determine potential risk factors that may increase dasatinib-associated glomerular injury. Methods: We...
9.
Havasi A, Heybeli C, Leung N, Angel-Korman A, Sanchorawala V, Cohen O, et al.
Blood Cancer J
. 2022 Aug;
12(8):119.
PMID: 35982035
Effective systemic therapies suppress toxic light chain production leading to an increased proportion of patients with light chain (AL) amyloidosis who survive longer albeit with end-stage renal disease. There is...
10.